Caption Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-100,000
Closed -$1.92M 1896
2025
Q1
$1.92M Buy
+100,000
New +$2.93M 0.02% 698
2021
Q3
Sell
-50,000
Closed -$4.87M 1805
2021
Q2
$4.87M Buy
+50,000
New +$4.46M 0.06% 373
2020
Q1
Sell
-30,000
Closed -$1.79M 1075
2019
Q4
$1.79M Buy
+30,000
New +$1.85M 0.06% 376
2019
Q2
Sell
-16,000
Closed -$1.02M 828
2019
Q1
$1.02M Sell
16,000
-87,700
-85% -$4.61M 0.06% 352
2018
Q4
$3.94M Buy
103,700
+88,800
+596% +$3.14M 0.31% 103
2018
Q3
$638K Sell
14,900
-125,100
-89% -$4.37M 0.04% 390
2018
Q2
$3.08M Buy
+140,000
New +$1.72M 0.24% 125

Other funds holding TNDM

Caption Management's TNDM Position: Q2 2026 in Review

Caption Management opened a new position in Tandem Diabetes Care (TNDM) in Q2 2026: 6,200 shares worth $93.6K. The stake represents ﹤0.01% of the portfolio and ranks #1527 among its holdings. This is a return to the name: Caption Management previously reported a position in TNDM as recently as Q3 2024.

Caption Management first reported a position in TNDM in Q4 2019 and has held it in 4 quarters since. The position peaked at $1.27M in Q3 2024. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Caption Management held 6,200 shares of Tandem Diabetes Care worth $93.6K as of Q2 2026.
  • Tandem Diabetes Care was a new Caption Management position in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Caption Management's portfolio in Q2 2026, its #1527 holding.
  • Caption Management first reported a position in Tandem Diabetes Care in Q4 2019 and has held it in 4 quarters since.
  • Caption Management's Tandem Diabetes Care position peaked at $1.27M in Q3 2024.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.